Scilex Holding Company Announces Publication in Pain Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (Semdexa™) in Lumbosacral Radicular Pain (Sciatica)
Scilex控股公司宣佈在疼痛期刊上公佈SP-102 (Semdexa™)在腰骶部根性疼痛(坐骨神經痛)的關鍵註冊試驗的第三階段結果。